Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023434416> ?p ?o ?g. }
- W2023434416 endingPage "g3320" @default.
- W2023434416 startingPage "g3320" @default.
- W2023434416 abstract "<h3>Abstract</h3> <h3>Background</h3> Vaccination is considered the most effective control measure against COVID-19. Vaccine hesitancy and equitable vaccine allocation are important challenges to disseminating developed vaccines. To promote COVID-19 vaccination coverage, the government of Japan established the workplace vaccination program. However, while it appears that the program was effective in overcoming vaccine hesitancy, the program may have hindered the equitable allocation of vaccines because it mainly focused on employees of large companies. We investigated the relationship between company size and COVID-19 vaccination completion status of employees and the impact of the workplace vaccination program on this relationship. <h3>Methods</h3> We conducted an internet-based prospective cohort study from December 2020 (baseline) to December 2021. The data were collected using a self-administered questionnaire survey. Briefly, 27,036 workers completed the questionnaire at baseline and 18,560 at follow-up. After excluding ineligible respondents, we finally analyzed the data from 15,829 participants. At baseline, the participants were asked about the size of the company they worked for, and at follow-up they were asked about the month in which they received their second COVID-19 vaccine dose and the availability of a company-arranged vaccination opportunity. Results: In each month throughout the observation period, the odds of having received a second COVID-19 vaccine dose were significantly lower for small-company employees than for large-company employees in the sex- and age-adjusted model. This difference decreased after adjusting for socioeconomic factors, and there was no significant difference after adjusting for the availability of a company-arranged vaccination opportunity. <h3>Conclusions</h3> The workplace vaccination program implemented in Japan to control the COVID-19 pandemic may have been effective in overcoming vaccine hesitancy in workers; however, it may have caused an inequitable allocation of vaccines between companies of different sizes. Because people who worked for small companies were less likely to be vaccinated, it will be necessary to enhance support of vaccination for this population in the event of future infectious disease outbreaks. <h3>Trial registration</h3> Not applicable." @default.
- W2023434416 created "2016-06-24" @default.
- W2023434416 creator A5044392782 @default.
- W2023434416 creator A5056355381 @default.
- W2023434416 date "2014-05-20" @default.
- W2023434416 modified "2023-09-25" @default.
- W2023434416 title "Whom should we test and treat for Helicobacter pylori?" @default.
- W2023434416 cites W1864949058 @default.
- W2023434416 cites W1870141890 @default.
- W2023434416 cites W1995658406 @default.
- W2023434416 cites W2002240959 @default.
- W2023434416 cites W2017289253 @default.
- W2023434416 cites W2021148036 @default.
- W2023434416 cites W2043985331 @default.
- W2023434416 cites W2056131972 @default.
- W2023434416 cites W2073208108 @default.
- W2023434416 cites W2077250146 @default.
- W2023434416 cites W2088196243 @default.
- W2023434416 cites W2095763692 @default.
- W2023434416 cites W2096989541 @default.
- W2023434416 cites W2099814577 @default.
- W2023434416 cites W2100000977 @default.
- W2023434416 cites W2100524810 @default.
- W2023434416 cites W2101365507 @default.
- W2023434416 cites W2111942462 @default.
- W2023434416 cites W2115280062 @default.
- W2023434416 cites W2118994384 @default.
- W2023434416 cites W2120822922 @default.
- W2023434416 cites W2122933597 @default.
- W2023434416 cites W2139464969 @default.
- W2023434416 cites W2139914972 @default.
- W2023434416 cites W2155270423 @default.
- W2023434416 cites W2165035434 @default.
- W2023434416 cites W2161899799 @default.
- W2023434416 cites W2170597349 @default.
- W2023434416 doi "https://doi.org/10.1136/bmj.g3320" @default.
- W2023434416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24846521" @default.
- W2023434416 hasPublicationYear "2014" @default.
- W2023434416 type Work @default.
- W2023434416 sameAs 2023434416 @default.
- W2023434416 citedByCount "9" @default.
- W2023434416 countsByYear W20234344162014 @default.
- W2023434416 countsByYear W20234344162015 @default.
- W2023434416 countsByYear W20234344162017 @default.
- W2023434416 countsByYear W20234344162019 @default.
- W2023434416 countsByYear W20234344162021 @default.
- W2023434416 crossrefType "journal-article" @default.
- W2023434416 hasAuthorship W2023434416A5044392782 @default.
- W2023434416 hasAuthorship W2023434416A5056355381 @default.
- W2023434416 hasConcept C111368507 @default.
- W2023434416 hasConcept C126322002 @default.
- W2023434416 hasConcept C12725497 @default.
- W2023434416 hasConcept C127313418 @default.
- W2023434416 hasConcept C138885662 @default.
- W2023434416 hasConcept C143095724 @default.
- W2023434416 hasConcept C144024400 @default.
- W2023434416 hasConcept C147077947 @default.
- W2023434416 hasConcept C149923435 @default.
- W2023434416 hasConcept C151730666 @default.
- W2023434416 hasConcept C151956035 @default.
- W2023434416 hasConcept C156957248 @default.
- W2023434416 hasConcept C203014093 @default.
- W2023434416 hasConcept C22070199 @default.
- W2023434416 hasConcept C2777267654 @default.
- W2023434416 hasConcept C2778137410 @default.
- W2023434416 hasConcept C2908647359 @default.
- W2023434416 hasConcept C41895202 @default.
- W2023434416 hasConcept C512399662 @default.
- W2023434416 hasConcept C71924100 @default.
- W2023434416 hasConcept C72563966 @default.
- W2023434416 hasConcept C86803240 @default.
- W2023434416 hasConcept C99454951 @default.
- W2023434416 hasConceptScore W2023434416C111368507 @default.
- W2023434416 hasConceptScore W2023434416C126322002 @default.
- W2023434416 hasConceptScore W2023434416C12725497 @default.
- W2023434416 hasConceptScore W2023434416C127313418 @default.
- W2023434416 hasConceptScore W2023434416C138885662 @default.
- W2023434416 hasConceptScore W2023434416C143095724 @default.
- W2023434416 hasConceptScore W2023434416C144024400 @default.
- W2023434416 hasConceptScore W2023434416C147077947 @default.
- W2023434416 hasConceptScore W2023434416C149923435 @default.
- W2023434416 hasConceptScore W2023434416C151730666 @default.
- W2023434416 hasConceptScore W2023434416C151956035 @default.
- W2023434416 hasConceptScore W2023434416C156957248 @default.
- W2023434416 hasConceptScore W2023434416C203014093 @default.
- W2023434416 hasConceptScore W2023434416C22070199 @default.
- W2023434416 hasConceptScore W2023434416C2777267654 @default.
- W2023434416 hasConceptScore W2023434416C2778137410 @default.
- W2023434416 hasConceptScore W2023434416C2908647359 @default.
- W2023434416 hasConceptScore W2023434416C41895202 @default.
- W2023434416 hasConceptScore W2023434416C512399662 @default.
- W2023434416 hasConceptScore W2023434416C71924100 @default.
- W2023434416 hasConceptScore W2023434416C72563966 @default.
- W2023434416 hasConceptScore W2023434416C86803240 @default.
- W2023434416 hasConceptScore W2023434416C99454951 @default.
- W2023434416 hasIssue "may20 4" @default.
- W2023434416 hasLocation W20234344161 @default.
- W2023434416 hasLocation W20234344162 @default.